Dicuno 50 mg Norge - norsk - Statens legemiddelverk

dicuno 50 mg

vitabalans oy - diklofenakkalium - tablett, filmdrasjert - 50 mg

Dicuno 25 mg Norge - norsk - Statens legemiddelverk

dicuno 25 mg

vitabalans oy - diklofenakkalium - tablett, filmdrasjert - 25 mg

Dectomax 5 mg/ ml Norge - norsk - Statens legemiddelverk

dectomax 5 mg/ ml

zoetis animal health aps - doramektin - påhellingsvæske, oppløsning - 5 mg/ ml

Dectomax 10 mg/ ml Norge - norsk - Statens legemiddelverk

dectomax 10 mg/ ml

zoetis animal health aps - doramektin - injeksjonsvæske, oppløsning - 10 mg/ ml

CircoMax Myco Den Europæiske Union - norsk - EMA (European Medicines Agency)

circomax myco

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologicals for suidae - griser (for fetende) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Diacomit Den Europæiske Union - norsk - EMA (European Medicines Agency)

diacomit

biocodex - stiripentol - myoclonic epilepsy, juvenile - antiepileptics, - diacomit er angitt for bruk i forbindelse med clobazam og valproate som tilleggsbehandling behandling av ildfaste generalisert tonisk-kloniske anfall hos pasienter med alvorlig myoclonic epilepsi i barndom (smei, dravets syndrom) hvis beslag ikke er tilstrekkelig kontrollert med clobazam og valproate.